Commentary on "Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis"

被引：0
|
作者：
Bsteh, Gabriel [1 ]
Berger, Thomas [1 ]
机构：
[1] Med Univ Vienna, Dept Neurol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 13期
关键词：
Teriflunomide; lymphocytic colitis; multiple sclerosis; adverse event; risk;
D O I：
10.1177/1352458520904546
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1803 / 1804
页数：2
相关论文
共 50 条
  • [1] Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis
    Son, Maksim
    McEwan, Lynn
    Ubaidat, Manaf
    Bovell, Keith
    Morrow, Sarah A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (13) : 1801 - 1803
  • [2] Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis
    Karly P. Garnock-Jones
    CNS Drugs, 2013, 27 : 1103 - 1123
  • [3] Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis
    Garnock-Jones, Karly P.
    CNS DRUGS, 2013, 27 (12) : 1103 - 1123
  • [4] Teriflunomide in relapsing multiple sclerosis: therapeutic utility
    Freedman, Mark S.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2013, 4 (05) : 192 - 205
  • [5] Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
    Lesley J. Scott
    Drugs, 2019, 79 : 875 - 886
  • [6] Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis
    Steinman, Lawrence
    Fox, Edward
    Hartung, Hans-Peter
    Alvarez, Enrique
    Qian, Peiqing
    Wray, Sibyl
    Robertson, Derrick
    Huang, DeRen
    Selmaj, Krzysztof
    Wynn, Daniel
    Cutter, Gary
    Mok, Koby
    Hsu, Yanzhi
    Xu, Yihuan
    Weiss, Michael S.
    Bosco, Jenna A.
    Power, Sean A.
    Lee, Lily
    Miskin, Hari P.
    Cree, Bruce A. C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (08): : 704 - 714
  • [7] Teriflunomide: A guide to its use in relapsing-remitting multiple sclerosis in the EU
    Keating G.M.
    Garnock-Jones K.P.
    Drugs & Therapy Perspectives, 2014, 30 (7) : 241 - 247
  • [8] Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
    Andrew Chan
    Jérôme de Seze
    Manuel Comabella
    CNS Drugs, 2016, 30 : 41 - 51
  • [9] Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
    O'Connor, Paul
    Wolinsky, Jerry S.
    Confavreux, Christian
    Comi, Giancarlo
    Kappos, Ludwig
    Olsson, Tomas P.
    Benzerdjeb, Hadj
    Truffinet, Philippe
    Wang, Lin
    Miller, Aaron
    Freedman, Mark S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1293 - 1303
  • [10] Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
    Sartori, Arianna
    Carle, Dawn
    Freedman, Mark S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 1019 - 1027
12345